Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Artificial Intelligence in Diagnostics Market, by Component
1.4.2 North America Artificial Intelligence in Diagnostics Market, by Diagnosis
1.4.3 North America Artificial Intelligence in Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.5 Porter Five Forces Analysis
Chapter 5. North America Artificial Intelligence in Diagnostics Market by Component
5.1 North America Software Market by Country
5.2 North America Hardware Market by Country
5.3 North America Services Market by Country
Chapter 6. North America Artificial Intelligence in Diagnostics Market by Diagnosis
6.1 North America Neurology Market by Country
6.2 North America Radiology Market by Country
6.3 North America Chest & Lung Market by Country
6.4 North America Oncology Market by Country
6.5 North America Cardiology Market by Country
6.6 North America Pathology Market by Country
6.7 North America Other Diagnosis Market by Country
Chapter 7. North America Artificial Intelligence in Diagnostics Market by Country
7.1 US Artificial Intelligence in Diagnostics Market
7.1.1 US Artificial Intelligence in Diagnostics Market by Component
7.1.2 US Artificial Intelligence in Diagnostics Market by Diagnosis
7.2 Canada Artificial Intelligence in Diagnostics Market
7.2.1 Canada Artificial Intelligence in Diagnostics Market by Component
7.2.2 Canada Artificial Intelligence in Diagnostics Market by Diagnosis
7.3 Mexico Artificial Intelligence in Diagnostics Market
7.3.1 Mexico Artificial Intelligence in Diagnostics Market by Component
7.3.2 Mexico Artificial Intelligence in Diagnostics Market by Diagnosis
7.4 Rest of North America Artificial Intelligence in Diagnostics Market
7.4.1 Rest of North America Artificial Intelligence in Diagnostics Market by Component
7.4.2 Rest of North America Artificial Intelligence in Diagnostics Market by Diagnosis
Chapter 8. Company Profiles
8.1 Siemens Healthineers AG (Siemens AG)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Zebra Technologies Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 GE HealthCare Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.6 SWOT Analysis
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Microsoft Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.6 SWOT Analysis
8.6 NVIDIA Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 IBM Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional & Segmental Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.6 SWOT Analysis
8.8 DeepScribe Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 AliveCor, Inc.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Digital Diagnostics, Inc. (3Derm Systems, Inc.)
8.10.1 Company Overview
Unique Offerings 